Common Side Effects of Zavzpret
Zavzpret (zavegepant), a nasal spray for acute migraine treatment, most often causes taste changes (dysgeusia) in about 20-22% of users. Other frequent reactions include nausea (5%), nasal discomfort (4%), and dry mouth (2-3%). These are typically mild and short-lived.[1][2]
Serious Side Effects and Warnings
Rare but serious effects include hypersensitivity reactions like facial swelling, rash, or breathing difficulty—stop use and seek medical help immediately. It carries a boxed warning for risk of hypersensitivity. Cardiovascular events (e.g., heart attack, stroke) have been reported with similar CGRP drugs, though not specifically linked to Zavzpret in trials. Avoid if you have cardiovascular disease or uncontrolled hypertension.[1][3]
How Side Effects Compare to Other Migraine Nasal Sprays
Compared to sumatriptan nasal spray, Zavzpret has fewer injection-site-like reactions but higher taste distortion. Ubrogepant (oral) shows similar nausea rates but no nasal issues. Clinical trials noted Zavzpret's side effects led to discontinuation in under 1% of patients.[2][4]
Who Experiences Side Effects Most?
Taste changes hit women and younger adults harder. Pre-existing nasal conditions worsen discomfort. Overuse (more than 8 doses/month) risks medication-overuse headache.[1][3]
What Patients Report After Use
Real-world feedback highlights metallic taste as the top complaint, often lasting minutes to hours. Some note mild nasal burning that fades quickly. No long-term data yet, as Zavzpret launched in 2023.[2][5]
[1]: Zavzpret Prescribing Information (Pfizer)
[2]: FDA Approval Summary
[3]: Drugs.com - Zavzpret Side Effects
[4]: NEJM Trial Data
[5]: DrugPatentWatch.com - Zavzpret Patient Reviews